The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) | MicrobiomeTrials← Back to trialsNCT04207944
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2020-07-10Est. Completion: 2026-07-30
Enrollment target: 100 participants Locations- Johns Hopkins University, Baltimore, Maryland, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Memorial Sloan Kettering, New York, New York, United States
- Duke University Medical Center, Durham, North Carolina, United States
Other microbiome trials you might be interested in
Intraductal Papillary Mucinous Neoplasm of PancreasPancreatic Neoplasms
This prospective pilot study will evaluate the diagnostic performance of a previously validated artificial intelligence …
Guayaquil, EcuadorEst. completion May 30, 2027
Pancreatic Diseases
This prospective observational study aims to investigate pathogenic myelopoiesis in patients with pancreatic ductal aden…
Multiple LocationsEst. completion Dec 31, 2027